To The Moon

  • Home
  • News
  • TigerAI
Log In Sign Up

Pharmaceutical Sector

The discoveries, deals driving Biotech & pharmaceutical industry.

0 followers
Login to post
  • NewsNews
  • PostsPosts
  • SelectionSelection
    • Novo Nordisk Raises Sales Outlook on Soaring Demand for Ozempic and Wegovy

      2023-10-14
    • Moderna, Bayer-Backed Startup Metagenomi Files for US IPO

      2024-01-07
    • CVS to Replace AbbVie’s Blockbuster Humira With Cheaper Rivals

      2024-01-04
    • Moderna Jumps Over 13% on Oppenheimer Upgrade, 2025 Sales Growth Goal

      2024-01-03
    • Judge Certifies Johnson & Johnson Shareholder Class Action Over Talc Disclosures

      2024-01-01
    • Argenx Tumbled Over 30% in Premarket Trading After Late-Stage Trial Didn't Meet Goals

      2023-12-20
    • Bluebird Bio Shares Fall 13% After Disclosing $150 Million Stock Offering

      2023-12-19
    • Innate Pharma SA Rose Over 10% in Premarket Trading As Sanofi Licensed Natural Killer Cell Engager Program From It

      2023-12-19
    • Pfizer Helped Save the World With Covid Vaccines. Now It Needs to Right Itself

      2023-12-15
    • Pfizer: Why Its FY2024 Downgrade Has Wall Street Wary

      2023-12-15
    • Pfizer Shares Dropped to Their Lowest Level in Over 10 Years—Here's Why

      2023-12-14
    • Is Pfizer Stock a Buy Now?

      2023-12-11
    • Pfizer Gets Europe OK for Elrexfio in Multiple Myeloma

      2023-12-11
    • Redhill Biopharma Stock Continues to Rise 71% After Surging 217% on Monday

      2023-11-28
    • Avidity Stock Soars 36% on Collaboration Deal With Bristol Myers

      2023-11-28
    • SpringWorks Jumps 14% After FDA Approves Non-Cancerous Tumors Treatment for Adults

      2023-11-28
    • Argenx Slumps 15% After Bleeding Disorder Drug Study Disappoints

      2023-11-28
    • Is Pfizer Stock a Buy Ahead of This Highly Anticipated Weight Loss Readout?

      2023-11-27
    • Medical Device Maker Medtronic Raises Fiscal 2024 Profit View

      2023-11-21
    • BioNTech Says European Patent Office Has Declared Moderna Patent Invalid

      2023-11-21
    • Gilead Quarterly Results Beat Street Estimates As Profit up on Lower Taxes

      2023-11-08
    • Cellectis Shares Soar 139% as AstraZeneca to Invest $245 Million in Deal With Cellectis

      2023-11-01
    • FDA Panel Says Vertex/CRISPR to Assess Safety Risks of Gene Therapy in Follow-up Study

      2023-11-01
    • GSK Stock Jumps After Raising Annual Forecasts Powered By Strong Arexvy Launch

      2023-11-01
    • Miromatrix Medical Stock Soars 236% After It Agrees to Be Bought By United Therapeutics

      2023-10-30
    • FDA Approves Pfizer's Vaccine for Meningococcal Disease

      2023-10-21
    • SeaStar Medical Stock More Than Doubles in 2 Days

      2023-10-20
    • Pfizer Cuts Guidance on Weakening Demand for Covid Antiviral Paxlovid

      2023-10-14
    • Tempest Dropped Over 59% During the Trading Hours and Slipped Over 10% in Extended Trading After 4,000% Gain

      2023-10-13
    • Tempest Therapeutics Jumps Over 3,900% on Wednesday As Liver-Cancer Treatment Shows Promise

      2023-10-12
    • FDA Authorizes Novavax's Updated COVID Shot

      2023-10-04
    • About 250,000 Courses of COVID Pill Paxlovid Being Administered Per Week - Pfizer CEO

      2023-09-27
    • Pfizer Restarts Production at Tornado-Damaged Facility, but Some Supply Is Still Affected

      2023-09-26
    • Avinger Surged Over 31% During the Trading Hours but Slipped Over 5% in Extended Trading on Wednesday

      2023-09-21
    • Avinger Soared Again on Tuesday: What's Going On?

      2023-09-20
    • Why Is Novo Integrated Sciences (NVOS) Stock Up 56% Wednesday?

      2023-08-17
    • Delcath Surges 90% on FDA Approval of Cancer Drug Device

      2023-08-15
    • Decibel Therapeutics Shares Soar on Acquisition by Regeneron Pharmaceuticals

      2023-08-10
    • Pfizer's Profits Plunge 77%: Is the Dividend Still Safe?

      2023-08-10
    • Eli Lilly Shares Ride Higher On Strong Q2 Performance, Diabetes and Weight Loss Treatment Mounjaro Nears $1B Revenue

      2023-08-08
    • Novavax Posts Unexpected Q2 Profit on Earlier COVID Revenue

      2023-08-08
    • Moderna Beats Q2 Top and Bottom Line Estimates; Updates FY23 Outlook

      2023-08-03
    • Moderna/Merck Begin Late-Stage Study of MRNA Cancer Vaccine

      2023-07-26
    • HeyaHeya
      ·2024-10-18
      For what its worth based on current prices, forget overvalued AI stocks the likes of PLTR , NVDA or AVGO Instead buy the dip in pharma counters like GSK and MRCK. This is the time to invest now if you have not added - both counters are favorites in hedgefunds lists because of their sure upside potential.  To add to that, GSK has received recent approvals and endorsements for new drug development. GSK announced the US Food and Drug Administration, FDA, has accepted the New Drug Application, NDA, for gepotidacin, an investigational, first-in-class oral antibiotic with a novel mechanism of action for the treatment of female adults and adolescents with uncomplicated urinary tract infections, uUTIs. The FDA has granted Priority Review for this application and assigned a Prescription D
      看2.05K回复Comment
      点赞42
      编组 21备份 2Share
      Report
    • Success88Success88
      ·2024-01-01
      Oic now I understand 

      Judge Certifies Johnson & Johnson Shareholder Class Action Over Talc Disclosures

      A federal judge said Johnson & Johnson shareholders may pursue as a class action their lawsuit accusing the company of fraudulently concealing how its talc products were contaminated by cancer-causing
      Judge Certifies Johnson & Johnson Shareholder Class Action Over Talc Disclosures
      看1.64K回复Comment
      点赞Like
      编组 21备份 2Share
      Report
    • MaverickWealthBuilderMaverickWealthBuilder
      ·2023-09-06

      What you have to know before Arm's IPO?

      $ARM Holdings Ltd(ARM)$ is set to be the largest IPO since 2021. According to its latest filings, price will be between $47 and $51 per share, with 95.5 million shares being offered. This puts ARM's IPO valuation between $50 billion and $54 billion, lower than the $64 billion valuation when $Softbank Group Corp(SFTBY)$ optained the remaining 25% stake last month.It also confirms major tech companies, including $Apple(AAPL)$ , $Alphabet(GOOG)$ $Alphabet(GOOGL)$ $Advanced Micro Devices(AMD)$ $NVIDIA
      看10.60K回复7
      点赞454
      编组 21备份 2Share
      Report
      What you have to know before Arm's IPO?
    • setia100setia100
      ·2023-08-22
      $Novavax(NVAX)$  Is it the threat from the return of the new COVID virus makes traders punting on it❓If not why it goes up 14% today ❗❗❗🤔
      看2.33K回复Comment
      点赞2
      编组 21备份 2Share
      Report
    Terms and Conditions Privacy Policy
    Company: TTMF Limited. Tech supported by Xiangshang Yixin. Email: uservice@ttm.financial